Evidence map›Paper›PMID 40475018›Full record

ArticleFrontiers in oncology2025

Breast cancer metastases to the stomach with endoscopic submucosal dissection: a case report and literature study.

Qingmiao Zhao, Lizhou Dou, Xiaolong Feng, Guiqi Wang, Shun He

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Recurrence of Breast Cancer With Scalp Metastasis.The Kaohsiung journal of medical sciences · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qingmiao Zhao *Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lizhou Dou *Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiaolong FengDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guiqi WangDepartment of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shun HeDepartment of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the second leading cause of cancer-related death in women, with mortality primarily associated with metastasis. Although gastric metastasis is rare, there are still case reports in the literature. Clinical symptoms of gastric metastasis from BC are often nonspecific, and endoscopic presentations are heterogeneous. Distinguishing between primary and metastatic tumors is important and challenging for the endoscopist. Herein, we report a case of gastric metastasis occurring 4 years after BC surgery. The timeline is as follows. In 2019, the 60-year-old woman received neoadjuvant chemotherapy followed by left breast radical surgery and endocrine therapy with targeted treatment. In 2022 (3 years post-surgery), left axillary metastasis was diagnosed, requiring excision of a skin mass. In 2023 (4 years post-surgery), she presented with upper abdominal pain and acid reflux, and gastroscopy revealed a superficial flat lesion in the gastric antrum. Immunohistochemical (IHC) staining suggested the possibility of poorly differentiated adenocarcinoma. Contrast-enhanced computed tomography (CT) revealed focal abnormal enhancement of the gastric antrum without evidence of distant metastasis. Since endoscopic, imaging, and IHC staining findings did not clearly suggest BC metastasis, and considering the patient's history of BC and overall condition, she underwent endoscopic submucosal dissection (ESD)-a procedure performed with both diagnostic and therapeutic intent. The postoperative pathology revealed metastatic invasive lobular carcinoma (ILC) of the breast. The ESD not only clarified the patients' diagnosis but also avoided unnecessary surgery for the patient. The patient remains alive under maintenance therapy. In summary, our case highlights the role of ESD, which was performed with both diagnostic and therapeutic intent-in managing gastric metastasis from BC, while underscoring the necessity of regular endoscopic surveillance post-mastectomy.

Indexed as

breast cancercase reportendoscopic submucosal dissectiongastric metastasisimmunohistochemistry

Identifiers

PMID40475018
PMCPMC12137079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.